New heart valves show promise for severe stenosis in indian patients

NCT ID NCT05171712

Completed Disease control Sponsor: Abbott Medical Devices Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested two new heart valves (Portico and Navitor) in 30 Indian patients with severe aortic stenosis, a condition where the heart's main valve narrows. The goal was to see if the valves are safe and work well. Researchers tracked complications and heart function for up to 9 months after the procedure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AORTIC INSUFFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

aortic valve insufficiency aortic valve stenosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AORTIC INSUFFICIENCY AORTIC STENOSIS AORTIC VALVE FAILURE AORTIC VALVE STENOSIS

Contacts and locations

Locations

Apollo Hospital

Chennai, India
Christian Medical College & Hospital

Vellore, India
Medanta-The Medicity

Gurgaon, India
Rajasthan Hospital

Jaipur, India
Seth GS Medical College & KEM Hospital

Mumbai, India
Vardhman Mahavir Medical College & Safdarjung Hospital

New Delhi, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.